Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor recommend KIT/PDGFRA gene testing for CD117/DOG1-negative GIST patients, which acts as a supplement for immunohistochemical diagnosis (Li et al., 2017). This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.